NMDA receptor-mediated extracellular adenosine accumulation is blocked by phosphatase 1/2A inhibitors

Brain Research

Volumn 1155, Issue 1, 2007, Pages 116-124

  Lu, Yin ^a   Rosenberg, Paul A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Adenosine; Epiletogenesis; Excitotoxicity; Neuroprotection; NMDA; Okadaic acid; Phosphatase 1 2A; Plasticity; Protein kinase C

Indexed keywords

ADENOSINE; ADENOSINE KINASE; CALCIUM; CALYCULIN A; ENZYME INHIBITOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OKADAIC ACID; PHOSPHATASE; PHOSPHATASE 1; PHOSPHATASE 2A; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CALCIUM TRANSPORT; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; EPILEPTOGENESIS; NERVE CELL PLASTICITY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SYNAPTIC TRANSMISSION;

ADENOSINE; ANIMALS; ENZYME INHIBITORS; INDOLES; MALEIMIDES; NAPHTHALENES; NEURONAL PLASTICITY; OXAZOLES; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

EID: 34250166501     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.04.057     Document Type: Article

References (71)

1. Beck F.W., Kaplan J., Fine N., Handschu W., and Prasad A.S. Decreased expression of CD73 (ecto-5′-nucleotidase) in the CD8+ subset is associated with zinc deficiency in human patients. J. Lab. Clin. Med. 130 (1997) 147-156
2. Bischofberger N., Jacobson and K.A., and Von Lubitz D.K.J.E. Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders. Ann. N.Y. Acad. Sci. 825 (1997) 23-29
3. Bonci A., and Williams J.T. A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 16 (1996) 631-639
4. Brand A., Vissiennon Z., Eschke D., and Nieber K. Adenosine A(1) and A(3) receptors mediate inhibition of synaptic transmission in rat cortical neurons. Neuropharmacology 40 (2001) 85-95
5. Braun N., Brendel P., and Zimmermann H. Distribution of 5′-nucleotidase in the developing mouse retina. Brain Res. Dev. Brain Res. 88 (1995) 79-86
6. Burke S.P., and Nadler J.V. Regulation of glutamate and aspartate release from slices of the hippocampal CA1 area: effects of adenosine and baclofen. J. Neurochem. 51 (1988) 1541-1551
7. Chamberlin N.L., Arrigoni E., Chou T.C., Scammell T.E., Greene R.W., and Saper C.B. Effects of adenosine on gabaergic synaptic inputs to identified ventrolateral preoptic neurons. Neuroscience 119 (2003) 913-918
8. Chan S.F., and Sucher N.J. An NMDA receptor signaling complex with protein phosphatase 2A. J. Neurosci. 21 (2001) 7985-7992
9. Chanchao C., Eristi C.M., Favis R., and Rutherford C.L. 5′-Nucleotidase in Dictyostelium: protein purification, cloning, and developmental expression. Biochim. Biophys. Acta 1473 (1999) 376-390
10. Colbran R.J. Targeting of calcium/calmodulin-dependent protein kinase. Biochem. J. 378 (2004) 1-16
11. Connick J.H., and Stone T.W. Quinolinic acid neurotoxicity: protection by intracerebral phenylisopropyladenosine (PIA) and potentiation by hypotension. Neurosci. Lett. 101 (1989) 191-196
12. Costenla A.R., Lopes L.V., de Mendonca A., and Ribeiro J.A. A functional role for adenosine A3 receptors: modulation of synaptic plasticity in the rat hippocampus. Neurosci. Lett. 302 (2001) 53-57
13. Dall'lgna O.P., Porciuncula L.O., Souza D.O., Cunha R.A., and Lara D.R. Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity. Br. J. Pharmacol. 138 (2003) 1207-1209
14. Dalpiaz A., and Manfredini S. Adenosine A(1) receptor: analysis of the potential therapeutic effects obtained by its activation in the central nervous system. Curr. Med. Chem. 9 (2002) 1923-1937
15. de Mendonca A., Almeida T., Bashir Z.I., and Ribeiro J.A. Endogenous adenosine attenuates long-term depression and depotentiation in the CA1 region of the rat hippocampus. Neuropharmacology 36 (1997) 161-167
16. Dolapchieva S.D. Electron microscopial localization of 5′-nucleotidase in the rat peripheral nerve fibers by cerium-based cytochemistry. J. Peripher. Nerv. Syst. 3 (1998) 254-258
17. Dolphin A.C., and Archer E.R. An adenosine agonist inhibits and a cyclic AMP analogue enhances the release of glutamate but not GABA from slices of rat dentate gyrus. Neurosci. Lett. 43 (1983) 49-54
18. Dunwiddie T.V. The physiological role of adenosine in the central nervous system. Int. Rev. Neurobiol. 27 (1985) 63-139
19. Enan E., and Matsumura F. Specific inhibition of calcineurin by type II synthetic pyrethroid insecticides. Biochem Pharmacol 43 (1992) 1777-1784
20. Fujii S., Kato H., Ito K., Itoh S., Yamazaki Y., Sasaki H., and Kuroda Y. Effects of A1 and A2 adenosine receptor antagonists on the induction and reversal of long-term potentiation in guinea pig hippocampal slices of CA1 neurons. Cell. Mol. Neurobiol. 20 (2000) 331-350
21. Galmarini C.M., Graham K., Thomas X., Calvo F., Rousselot P., El Jafaari A., Cros E., Mackey J.R., and Dumontet C. Expression of high Km 5′-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia. Blood 98 (2001) 1922-1926
22. Goldberg M.P., Monyer H., Weiss J.H., and Choi D.W. Adenosine reduces cortical neuronal injury induced by oxygen or glucose deprivation in vitro. Neurosci. Lett. 89 (1988) 323-327
23. Greene R.W., and Haas H.L. The electrophysiology of adenosine in the mammalian central nervous system. Prog. Neurobiol. 36 (1991) 329-341
24. Grider A., Lin Y.F., and Muga S.J. Differences in the cellular zinc content and 5′-nucleotidase activity of normal and acrodermatitis enteropathica (AE) fibroblasts. Biol. Trace Elem. Res. 61 (1998) 1-8
25. Groth R.D., Dunbar R.L., and Mermelstein P.G. Calcineurin regulation of neuronal plasticity. Biochem. Biophys. Res. Commun. 311 (2003) 1159-1171
26. Gustafson L.A., Zuurbier C.J., Bassett J.E., Barends J.P., van Beek J.H., Bassingthwaighte J.B., and Kroll K. Increased hypoxic stress decreases AMP hydrolysis in rabbit heart. Cardiovasc. Res. 44 (1999) 333-343
27. Halpain S., and Greengard P. Activation of NMDA receptors induces rapid dephosphorylation of the cytoskeletal protein MAP2. Neuron 5 (1990) 237-246
28. Harrison G.J., Willis R.J., and Headrick J.P. Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart. Cardiovasc. Res. 40 (1998) 74-87
29. Haystead T.A., Sim A.T., Carling D., Honnor R.C., Tsukitani Y., Cohen P., and Hardie D.G. Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism. Nature 337 (1989) 78-81
30. Herbert J.M., Augereau J.M., Gleye J., and Maffrand J.P. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172 (1990) 993-999
31. Herzig S., and Neumann J. Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol. Rev. 80 (2000) 173-210
32. Ikeda K., Kurokawa M., Aoyama S., and Kuwana Y. Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease. J. Neurochem. 80 (2002) 262-270
33. Ishihara H., Martin B.L., Brautigan D.L., Karaki H., Ozaki H., Kato Y., Fusetani N., Watabe S., Hashimoto K., Uemura D., et al. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem. Biophys. Res. Commun. 159 (1989) 871-877
34. Jackisch R., Strittmatter H., Kasakov L., and Hertting G. Endogenous adenosine as a modulator of hippocampal acetylcholine release. Naunyn-Schmiedebergs Arch. Pharmakol. 327 (1984) 319-325
35. Kitakaze M., Minamino T., Node K., Komamura K., Inoue M., Hori M., and Kamada T. Activation of ecto-5′-nucleotidase by protein kinase C attenuates irreversible cellular injury due to hypoxia and reoxygenation in rat cardiomyocytes. J. Mol. Cell. Cardiol. 28 (1996) 1945-1955
36. Klumpp S., and Krieglstein J. Serine/threonine protein phosphatases in apoptosis. Curr. Opin. Pharmacol. 2 (2002) 458-462
37. Kobayashi E., Nakano H., Morimoto M., and Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159 (1989) 548-553
38. Lu Y., Chung H.J., Li Y., and Rosenberg P.A. NMDA receptor-mediated extracellular adenosine accumulation in rat forebrain neurons in culture is associated with inhibition of adenosine kinase. Eur. J. Neurosci. 17 (2003) 1213-1222
39. Ludwig H.C., Rausch S., Schallock K., and Markakis E. Expression of CD 73 (ecto-5′-nucleotidase) in 165 glioblastomas by immunohistochemistry and electronmicroscopic histochemistry. Anticancer Res. 19 (1999) 1747-1752
40. Lynch J.J., Alexander K.M., Jarvis M.F., and Kowaluk E.A. Inhibition of adenosine kinase during oxygen-glucose deprivation in rat cortical neuronal cultures. Neurosci. Lett. 252 (1998) 207-210
41. Madrid-Marina V., and Fox I.H. Human placental cytoplasmic 5′-nucleotidase. Kinetic properties and inhibition. J. Biol. Chem. 261 (1986) 444-452
42. McIlwain H., and Poll J.D. Adenosine in cerebral homeostatic role: appraisal through actions of homocysteine, colchicine, and dipyridamole. J. Neurobiol. 17 (1986) 39-49
43. Metzger F., and Kapfhammer J.P. Protein kinase C: its role in activity-dependent Purkinje cell dendritic development and plasticity. Cerebellum 2 (2003) 206-214
44. Montoro R.J., Diaz-Nido J., Avila J., and Lopez-Barneo J. N-methyl-d-aspartate stimulates the dephosphorylation of the microtubule-associated protein 2 and potentiates excitatory synaptic pathways in the rat hippocampus. Neuroscience 54 (1993) 859-871
45. Moriwaki Y., Yamamoto T., and Higashino K. Enzymes involved in purine metabolism-a review of histochemical localization and functional implications. Histol. Histopathol. 14 (1999) 1321-1340
46. Nijholt I., Blank T., Liu A., Kugler H., and Spiess J. Modulation of hypothalamic NMDA receptor function by cyclic AMP-dependent protein kinase and phosphatases. J. Neurochem. 75 (2000) 749-754
47. Nishi A., Bibb J.A., Matsuyama S., Hamada M., Higashi H., Nairn A.C., and Greengard P. Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A. J. Neurochem. 81 (2002) 832-841
48. Page T., Yu A., Fontanesi J., and Nyhan W.L. Developmental disorder associated with increased cellular nucleotidase activity. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 11601-11606
49. Pesi R., Turriani M., Allegrini S., Scolozzi C., Camici M., Ipata P.L., and Tozzi M.G. The bifunctional cytosolic 5′-nucleotidase: regulation of the phosphotransferase and nucleotidase activities. Arch. Biochem. Biophys. 312 (1994) 75-80
50. Phillis J.W., Kostopoulos G.K., and Limacher J.J. A potent depressant action of adenine derivatives on cerebral cortical neurones. Eur. J. Pharmacol. 30 (1975) 125-129
51. Price N.E., and Mumby M.C. Brain protein serine/threonine phosphatases. Curr. Opin. Neurobiol. 9 (1999) 336-342
52. Resta R., and Thompson L.F. T cell signalling through CD73. Cell. Signal. 9 (1997) 131-139
53. Ribeiro J.A., Sebastiao A.M., and de Mendonca A. Adenosine receptors in the nervous system: pathophysiological implications. Prog. Neurobiol. 68 (2002) 377-392
54. Rosenberg P.A., Li Y., Le M., and Zhang Y. Nitric oxide-stimulated increase in extracellular adenosine accumulation in rat forebrain neurons in culture is associated with ATP hydrolysis and inhibition of adenosine kinase activity. J. Neurosci. 20 (2000) 6294-6301
55. Rusnak F., and Mertz P. Calcineurin: form and function. Physiol. Rev. 80 (2000) 1483-1521
56. Schoen S.W., and Kreutzberg G.W. 5′-Nucleotidase enzyme cytochemistry as a tool for revealing activated glial cells and malleable synapses in CNS development and regeneration. Brain Res. Brain Res. Protoc. 1 (1997) 33-43
57. Shi J., Townsend M., and Constantine-Paton M. Activity-dependent induction of tonic calcineurin activity mediates a rapid developmental downregulation of NMDA receptor currents. Neuron 28 (2000) 103-114
58. Sim A.T., Baldwin M.L., Rostas J.A., Holst J., and Ludowyke R.I. The role of serine/threonine protein phosphatases in exocytosis. Biochem. J. 373 (2003) 641-659
59. Snyder G.L., Fienberg A.A., Huganir R.L., and Greengard P. A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. J. Neurosci. 18 (1998) 10297-10303
60. Spychala J., Madrid-Marina V., and Fox I.H. High Km soluble 5′-nucleotidase from human placenta. Properties and allosteric regulation by IMP and ATP. J. Biol. Chem. 263 (1988) 18759-18765
61. Stone T.W. Purines and neuroprotection. Adv. Exp. Med. Biol. 513 (2002) 249-280
62. Suganuma M., Fujiki H., Furuya-Suguri H., Yoshizawa S., Yasumoto S., Kato Y., Fusetani N., and Sugimura T. Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin. Cancer Res. 50 (1990) 3521-3525
63. Takai A. Okadaic acid. Protein phosphatase inhibition and muscle contractile effects. J. Muscle Res. Cell Motil. 9 (1988) 563-565
64. Thomas M.J., Moody T.D., Makhinson M., and O'Dell T.J. Activity-dependent beta-adrenergic modulation of low frequency stimulation induced LTP in the hippocampal CA1 region. Neuron 17 (1996) 475-482
65. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F., et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266 (1991) 15771-15781
66. Von Lubitz D.K., Lin R.C., Bischofberger N., Beenhakker M., Boyd M., Lipartowska R., and Jacobson K.A. Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist. Eur. J. Pharmacol. 369 (1999) 313-317
67. Waltereit R., and Weller M. Signaling from cAMP/PKA to MAPK and synaptic plasticity. Mol. Neurobiol. 27 (2003) 99-106
68. Wang L.Y., Orser B.A., Brautigan D.L., and MacDonald J.F. Regulation of NMDA receptors in cultured hippocampal neurons by protein phosphatases 1 and 2A. Nature 369 (1994) 230-232
69. Wang G.J., Chung H.J., Schnuer J., Pratt K., Zable A.C., Kavanaugh M.P., and Rosenberg P.A. High affinity glutamate transport in rat cortical neurons in culture. Mol. Pharmacol. 53 (1998) 88-96
70. Winder D.G., and Sweatt J.D. Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. Nat. Rev., Neurosci. 2 (2001) 461-474
71. Zimmermann H. Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Prog. Neurobiol. 49 (1996) 589-618